Clinical Trial Update: Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

Phase 1b, open-label study evaluating safety, pharmacokinetics and pharmacodynamics of Tune-401 in adults with chronic hepatitis B; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tune-401

Snippet

Sponsor: Tune Therapeutics, Inc. | Conditions: Chronic Hep B, Chronic Hepatitis b | Phase 1 | Status: RECRUITING